Artificial intelligence (AI) is transforming the world in much the same way as the adoption of the internet did 30 years ago. This is about more than just search; AI is changing the way many industries handle administrative tasks. One area undergoing a significant transformation is healthcare. The use of generative and agentic AI is helping physicians and care teams make more accurate diagnoses, streamline administrative tasks, and reduce the risk of provider burnout. According to Athenahealth’s third Physi ...

心脏是人类最重要的器官之一，它现在日益得到AI的"关照"。 "它即使不能诊断，但是可以把大量垃圾信息给删掉，把一些阳性的信息提供给医生。"上海长征医院心 内科主任梁春对第一财经记者表示。 9月24日的"带疱伤心，主动联防"世界心脏日科普活动上，梁春表示AI已经深度介入医生的工作流程， 提高医生工作效率。当下医疗器械企业、科技公司、学术界，都在向心脏注入AI的力量。华为、苹果 等消费电子公司开发的手表已经能够为佩戴者提示心脏房颤（心房失去了规律的节律）风险；医疗器械 企业比如波士顿科学开始借助AI帮医生评估冠状动脉阻塞程度；王建安院士的研究显示借助AI精准诊 断能减少一成的心脏支架植入。 中国心血管疾病患者人数超过3亿，资金和AI研发力量正在集聚。但AI的发展不会一帆风顺，数据的匮 乏影响它对心脏疾病的诊断和治疗，这需要时间来改善。谁能用AI征服心脏，谁才能赢得下一个十 年。 心尖上的AI 心脏是人类最重要的器官之一，它现在日益得到AI的"关照"。 冠心病是人类健康杀手，它通常由冠状动脉粥样硬化导致。冠状动脉是供给心脏血液的动脉，它的管腔 狭窄或阻塞，轻则引起胸闷和疼痛，重则有致命风险。对这条奔流着生命血液的动 ...

Key Takeaways Boston Scientific expanded in oncology and hypertension with Intera Oncology and SoniVie deals. Acquisitions boosted BSX Q2 revenues by 450 basis points, strengthening therapeutic portfolios. BSX's WATCHMAN franchise grew 28% in Q2, aided by CE Mark for next-gen FLX Pro device. Boston Scientific (BSX) is poised for growth in the upcoming quarters, driven by its impressive strategic acquisitions. The long-term prospects of the WATCHMAN devices are encouraging. Meanwhile, headwinds like currency ...

有些伤口，永远难以愈合。 这个男人自小由母亲一手拉扯长大。 在读书、工作、创业的岁月里，每当夜深人静，因为合作伙伴的争执、产品的试错、融资的压力而辗转难眠时，他总会想起那张父亲的军装照。 虽然面容早已模糊。但那份缺席，却成为他最持久的动力。 在 66 岁那年，他终于在白令海 2700 英尺的深处，找到了父亲和 70 名官兵的潜艇残骸，长期的追寻有了答案。 他就是 波士顿科学的联合创始人 ——约翰·阿贝尔（John Abele）。 从海军遗孤到"好奇心驱动"的少年 约翰出生于1937年。父亲 Mannert L. Abele 是一名海军潜艇指挥官，1942 年驾驶 USS Grunion 在阿留申群岛战役中失踪，全艇 70 人葬身深海。 （珍珠港事件后，与日军作战中沉没） 当时的约翰只有4岁多。父亲的缺席让他从小在母亲与兄弟的陪伴下长大，也在他心中埋下了"寻找真相"的执念。 他在阿默斯特学院学习物理和哲学，一个是理性，一个是人文，这种跨界背景塑造了他后来在创新和组织行为上的独特视角。 大学毕业后，他先在中西部的一家灯具公司短暂工作，随后进入波士顿附近的一家小型医疗企业，开始接触医疗器械行业，并逐渐形成了"通过更 ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Boston Scientific Corporation is one of them Boston Scientific Corporation (NYSE:BSX) is emerging as a top AI-powered biotech stock by embedding artificial intelligence into its medical device portfolio, particularly in cardiology. Its AI strategy focuses on integrating advanced algorithms directly into revenue-generating devices like the WATCHMAN and FARAPULSE pulsed field ablation system, enhancing clinical out ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...

United Kingdom Paroxysmal Supraventricular Tachycardia Market Research Report (2025) By Leading Players, Emerging Technologies, Opportunity 2032shivani11 min read·Just nowJust now--Press enter or click to view image in full size“What is the current size and growth rate of the Paroxysmal Supraventricular Tachycardia Market?The global Paroxysmal Supraventricular Tachycardia Market was valued at USD 1.35 billion in 2024.It is projected to achieve a market valuation of USD 2.12 billion by 2032, exhibiting a Com ...

Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts. On September 11, analysts at Needham reiterated a ‘Buy’ rating on the stock and a $121 price target. The positive stance comes as the company plans to launch Bolt’s laser-based intravascular lithotripsy (IVL) system for peripheral use in late 2025. Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity Image: Courtesy of Boston Scientific The company has already c ...

Institutional interest in medical device makers is holding up—and, in some corners, building—on the back of solid operating updates from industry bellwethers. Hedge fund Armistice Capital has been adding to small- and mid-cap device names, while BlackRock and State Street continue to channel sizable client assets into the space through sector funds and broad index vehicles that leave them among the largest shareholders of blue-chip manufacturers. Recent quarterly results from device leaders have reinforced ...